Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4702 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-82 |
filingDate |
2004-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00c4e7744f8400a123a8c7f62fccc9ac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5410bb039782fbd2fab2f94372e16eed |
publicationDate |
2005-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2005119185-A1 |
titleOfInvention |
Synthetic HLA binding peptide analogues and uses thereof |
abstract |
The present invention provides synthetic peptides comprising at least analogues of a native peptide that specifically bind to HLA A0201 or HLA A0301 molecules on a cell characteristic of a pathophysiologic state, such as a cancer cell, in a mammal. Also provided are pharmaceutical compositions and immunogenic compositions comprising at least the peptide analogue segments or a DNA encoding the same. Also provided are methods of using the synthetic peptides and immunogenic compositions to induce a heteroclitic immune response or to treat a cancer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3520810-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10100087-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011071214-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10815273-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10815274-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9919037-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2009066462-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007120673-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11548924-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007047763-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11414457-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2216041-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10221224-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114149970-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009137872-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010255020-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2802347-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007047763-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2216041-A1 |
priorityDate |
2003-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |